MedPath

Ketamine assisted group mindfulness for alcohol use disorder

Phase 2
Conditions
Alcohol Use Disorder
Mental Health - Addiction
Registration Number
ACTRN12622000245796
Lead Sponsor
niversity of Otago
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Capable of understanding and signing an informed consent
Aged 18 years and over, and under 70 years old on the day of consent
Have an established diagnosis of moderate to severe AUD

Exclusion Criteria

Female participants who are or intend to become pregnant or are lactating.
Participants who, in the opinion of the investigator, do not understand the information and procedures of the study, or would not be compliant with them.
Any participant for whom the investigator believes, for any reason, that participation would not be an acceptable risk.
Participants who are starting new antidepressants, anxiolytics or psychotherapy within four weeks of enrolment. Use of antidepressants, anxiolytics at stable doses > four weeks prior or psychotherapy is acceptable.
Active suicidal ideation as operationalise by a CSSR score of four or higher.
Participants with comorbid schizophrenia or bipolar disorder. Depression and anxiety is acceptable.
Participants with current other moderate to severe substance use disorder other than nicotine or caffeine.
Participants with severe personality disorders as judged elevated risk by the investigator.
Participants who are on parole.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath